Systemic Scleroderma Treatment will surge to a market valuation of US$ 1.74 Bn by the end of 2032 NEW YORK, April 21, 2022 (GLOBE NEWSWIRE) -- In 2021, the systemic scleroderma treatment market was valued at nearly US$ 749.4 Mn, and is estimated to expand at a CAGR of 8% over the forecast period...